Article
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge
2022-02-01
Abstract excerpt
<title>Abstract</title> <p>To establish a novel SARS-CoV-2 human challenge model, 36 volunteers aged 18-29 years without evidence of previous infection or vaccination were inoculated with 10 TCID<sub>50</sub> of a wild-type virus (SARS-CoV-2/human/GBR/484861/2020) intranasally. Two participants were excluded from per protocol analysis due to seroconversion between screening and inoculation. Eighteen (~53%) became...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9b5240a2-d612-5035-9eb9-d3891e3edea6
- DOI
- 10.21203/rs.3.rs-1121993/v1
